
Ian Kerridge
Articles
-
Feb 22, 2024 |
onlinelibrary.wiley.com | Sophie C Lewis |Camille La Brooy |Ian Kerridge |Alex Holmes
INTRODUCTION In 2023, voluntary assisted dying (VAD) became lawful in all Australian states; joining other jurisdictions including the Netherlands, Belgium, Switzerland, Canada, and others in legalising assisted dying (Downie et al., 2022; Duckett, 2019; Mroz et al., 2021). This new health policy direction is a significant change in the social and medico-legal landscape of end-of-life care.
-
Nov 2, 2023 |
smh.com.au | Ian Kerridge |Wendy Lipworth
Then, quite remarkably, in 1995 Miles stopped practising surgery to establish an ethics centre at the University of Sydney - the Centre for Values, Ethics and the Law in Medicine (VELiM) - because he believed that medicine had lost sight of its moral base and humanist foundations, and had begun to serve technocratic and scientific imperatives instead of the lives and interests of patients and communities.
-
Nov 2, 2023 |
brisbanetimes.com.au | Ian Kerridge |Wendy Lipworth
By Ian Kerridge and Wendy Lipworth November 2, 2023 — 1.58pm, register or subscribe to save articles for later. Add articles to your saved list and come back to them any time. JOHN MILES LITTLE: 1933 – 2023Miles Little was a visionary who changed the landscape of medicine and medical ethics through the force of his ideas.
-
Jul 31, 2023 |
onlinelibrary.wiley.com | George Mason |Ian Kerridge |Anthony Jeffrey |Poomahal Kumar
A 30 year old female presented with a 4 month history of an enlarging right posterior thigh mass. Biopsy of the lesion demonstrated an angioinvasive atypical lymphoid infiltrate with pleomorphic nuclei and prominent nucleoli. The immunohistochemical profile was consistent with a diagnosis of extranodal NK/T cell lymphoma: atypical lymphoid cells were positive for CD2, CD3, CD7, CD45RO, CD30, CD8 and cytotoxic molecules (Granzyme B, TIA1, Perforin). CD5 was lost in most cells.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →